Literature DB >> 32400742

Diagnostic significance of biochemical markers and pentraxin-3 in the differential diagnosis of malign, benign pleural effusion and empyema.

Isa Dongel1, Aysegul Aksoy Gokmen2, Hasan Ekrem Camas3, Ibak Gonen4, Selcuk Kaya2.   

Abstract

OBJECTIVE: To investigate the diagnostic significance of biochemical markers and pentraxin-3 in the differential diagnosis of pleural effusions.
METHODS: The prospective clinical study was conducted at the Suleyman Demirel University, Isparta, Turkey, from January 2013 to June 2014, and comprised patients with pleural effusion. Pleural effusions were tested for glucose, protein, lactate dehydrogenase, and pentraxin 3 while simultaneous C-reactive protein and white blood cell levels were studied in the serums. Data was analysed using SPSS 22.
RESULTS: Of the 96 patients, 48(50%) had malignant disease, 33(34%) had benign pleural effusion, and 15(16%) had empyema. In terms of glucose, protein, lactate dehydrogenase in the pleural effusions and C-reactive protein values in serums, significant differences were observed among the three groups (p<0.05). The pentraxin-3 levels in the empyema group was significantly higher than in the benign cases (p<0.033). No significant difference was observed in terms of the other variables between the groups (p>0.05).
CONCLUSIONS: Serum C-reactive protein and pentraxin-3 levels were not found to be individually conclusive in the differential diagnosis of pleural effusion. Also, lactate dehydrogenase levels were higher and glucose levels were lower in empyema.

Entities:  

Keywords:  Pentraxin-3, Empyema, Pleural effusion, C-reactive protein, White blood cell. zzm321990zzm321990

Mesh:

Substances:

Year:  2020        PMID: 32400742     DOI: 10.5455/JPMA.17181

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  1 in total

1.  Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions.

Authors:  Hatice Elmas; Christian Biancosino; Binnur Önal; Fernando Schmitt; Seyma Buyucek; Gerhard Nordholt; Guido Sauter; Lutz Welker
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.